Vascular Pharmacology

Papers
(The H4-Index of Vascular Pharmacology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Corrigendum to “Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis” [Vascular Pharmacology 155 (2024) 107106
Patterns of medication use and potential drug-drug interactions in post-PCI patients: A study from Iran100
Graphical abstract TOC48
Biobanks: The unmet need in heart failure management37
Graphical abstract TOC36
The transfer of gut microbiota/metabolites from children to mice affects cardiometabolic development and induces sex-dimorphism in recipients34
Animal experimental models of ischemic limbs – A systematic review25
Therapy and guideline adherence at a multidisciplinary hypertension clinic: A prospective, observational study24
The MEK-ERK-Egr-1 axis and its regulation in cardiovascular disease23
Prevalence of antiphospholipid antibodies in COVID-19 patients: A meta-analysis23
Molecular mechanisms of flavonoids in myocardial ischemia reperfusion injury: Evidence from in-vitro and in-vivo studies23
A random shuffle method to expand a narrow dataset: A heart failure cohort example22
Editorial Board22
Exploiting endothelial functions in bone regenerative medicine21
Prevention of cardiovascular complications in elderly cancer patients20
Optical stimulation of endothelial colony forming cells plated on light-sensitive conjugated polymers induces a TRPV1-mediated increase in intracellular Ca2+ concentration20
Doxorubicin-induced cardiotoxicity enhance SARS-CoV-2 infection susceptibility in human cardiomyocytes20
Editorial Board19
Editorial Board19
0.030602931976318